These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28539659)

  • 1. Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia.
    Bastide MF; Glangetas C; Doudnikoff E; Li Q; Bourdenx M; Fernagut PO; Dumont ÉC; Georges F; Bézard E
    Sci Rep; 2017 May; 7(1):2348. PubMed ID: 28539659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Lateral Habenula Improves L-DOPA-Induced Dyskinesia.
    Bastide MF; de la Crompe B; Doudnikoff E; Fernagut PO; Gross CE; Mallet N; Boraud T; Bézard E
    Biol Psychiatry; 2016 Mar; 79(5):345-353. PubMed ID: 25442003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Inactivation of Striatal FosB/ΔFosB-Expressing Neurons Alleviates L-DOPA-Induced Dyskinesia.
    Engeln M; Bastide MF; Toulmé E; Dehay B; Bourdenx M; Doudnikoff E; Li Q; Gross CE; Boué-Grabot E; Pisani A; Bezard E; Fernagut PO
    Biol Psychiatry; 2016 Mar; 79(5):354-361. PubMed ID: 25146322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia.
    Bastide MF; Dovero S; Charron G; Porras G; Gross CE; Fernagut PO; Bézard E
    Neurobiol Dis; 2014 Feb; 62():179-92. PubMed ID: 24103779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.
    Steece-Collier K; Collier TJ; Lipton JW; Stancati JA; Winn ME; Cole-Strauss A; Sellnow R; Conti MM; Mercado NM; Nillni EA; Sortwell CE; Manfredsson FP; Bishop C
    Exp Neurol; 2020 Aug; 330():113327. PubMed ID: 32387398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.
    Mulas G; Espa E; Fenu S; Spiga S; Cossu G; Pillai E; Carboni E; Simbula G; Jadžić D; Angius F; Spolitu S; Batetta B; Lecca D; Giuffrida A; Carta AR
    Exp Neurol; 2016 Dec; 286():83-92. PubMed ID: 27697481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
    Solís O; Espadas I; Del-Bel EA; Moratalla R
    Neurobiol Dis; 2015 Jan; 73():49-59. PubMed ID: 25281315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
    Lane EL; Vercammen L; Cenci MA; Brundin P
    Exp Neurol; 2009 Sep; 219(1):355-8. PubMed ID: 19393238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gypenosides attenuate the development of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Shin KS; Zhao TT; Park KH; Park HJ; Hwang BY; Lee CK; Lee MK
    BMC Neurosci; 2015 Apr; 16():23. PubMed ID: 25896846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.
    Padovan-Neto FE; Ferreira NR; de Oliveira-Tavares D; de Aguiar D; da Silva CA; Raisman-Vozari R; Del Bel E
    Neurosci Lett; 2013 Apr; 541():126-31. PubMed ID: 23428503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Keber U; Klietz M; Carlsson T; Oertel WH; Weihe E; Schäfer MK; Höglinger GU; Depboylu C
    Neuroscience; 2015 Jul; 298():302-17. PubMed ID: 25892702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal NELF-mediated RNA polymerase II stalling controls L-dopa induced dyskinesia.
    Bastide MF; Bido S; Duteil N; Bézard E
    Neurobiol Dis; 2016 Jan; 85():93-98. PubMed ID: 26480869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N; Martín AB; Mendialdua A; Moratalla R
    Biol Psychiatry; 2006 Jan; 59(1):64-74. PubMed ID: 16139809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A; Li Q; Gardoni F; Marcello E; Qin C; Carlsson T; Kirik D; Di Luca M; Björklund A; Bezard E; Carta M
    Brain; 2008 Dec; 131(Pt 12):3380-94. PubMed ID: 18952677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease.
    Palafox-Sanchez V; Sosti V; Ramirez-García G; Kulisevsky J; Aguilera J; Limón ID
    Neurotox Res; 2019 Apr; 35(3):563-574. PubMed ID: 30645726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons.
    Klietz M; Keber U; Carlsson T; Chiu WH; Höglinger GU; Weihe E; Schäfer MK; Depboylu C
    Neuroscience; 2016 Sep; 331():120-33. PubMed ID: 27320210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
    Wang Y; Wang HS; Wang T; Huang C; Liu J
    J Neurosci Res; 2014 Dec; 92(12):1733-45. PubMed ID: 24975553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levodopa/benserazide microspheres reduced levodopa-induced dyskinesia by downregulating phosphorylated GluR1 expression in 6-OHDA-lesioned rats.
    Yang X; Chen Y; Hong X; Wu N; Song L; Yuan W; Liu Z
    Drug Des Devel Ther; 2012; 6():341-7. PubMed ID: 23185117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological antagonism of histamine H2R ameliorated L-DOPA-induced dyskinesia via normalization of GRK3 and by suppressing FosB and ERK in PD.
    Ahmed MR; Jayakumar M; Ahmed MS; Zamaleeva AI; Tao J; Li EH; Job JK; Pittenger C; Ohtsu H; Rajadas J
    Neurobiol Aging; 2019 Sep; 81():177-189. PubMed ID: 31306812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The involvement of RGS9 in l-3,4-dihydroxyphenylalanine-induced dyskinesias in unilateral 6-OHDA lesion rat model.
    Yin LL; Geng XC; Zhu XZ
    Brain Res Bull; 2011 Nov; 86(5-6):367-72. PubMed ID: 21963945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.